CSII
Income statement / Annual
Last year (2022), Cardiovascular Systems, Inc.'s total revenue was $236.22 M,
a decrease of 8.79% from the previous year.
In 2022, Cardiovascular Systems, Inc.'s net income was -$36.93 M.
See Cardiovascular Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
06/30/2014 |
06/30/2013 |
| Operating Revenue |
$236.22 M |
$258.97 M |
$236.55 M |
$248.02 M |
$217.04 M |
$204.91 M |
$178.18 M |
$181.54 M |
$136.61 M |
$103.90 M |
| Cost of Revenue |
$63.44 M
|
$61.13 M
|
$48.76 M
|
$47.68 M
|
$39.48 M
|
$39.44 M
|
$35.42 M
|
$39.52 M
|
$31.04 M
|
$24.38 M
|
| Gross Profit |
$172.78 M
|
$197.84 M
|
$187.79 M
|
$200.34 M
|
$177.56 M
|
$165.47 M
|
$142.76 M
|
$142.02 M
|
$105.57 M
|
$79.52 M
|
| Gross Profit Ratio |
0.73
|
0.76
|
0.79
|
0.81
|
0.82
|
0.81
|
0.8
|
0.78
|
0.77
|
0.77
|
| Research and Development Expenses |
$36.72 M
|
$41.06 M
|
$43.36 M
|
$33.46 M
|
$26.76 M
|
$22.91 M
|
$25.93 M
|
$30.98 M
|
$21.07 M
|
$15.22 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$167.70 M
|
$148.57 M
|
$144.10 M
|
$162.54 M
|
$143.68 M
|
$117.99 M
|
$86.72 M
|
| Selling, General & Administrative Expenses |
$170.53 M
|
$167.50 M
|
$169.97 M
|
$167.70 M
|
$148.57 M
|
$144.10 M
|
$162.54 M
|
$143.68 M
|
$117.99 M
|
$86.72 M
|
| Other Expenses |
$1.34 M
|
$1.22 M
|
$1.23 M
|
$760,000.00
|
-$390,000.00
|
-$164,000.00
|
$53,000.00
|
-$162,000.00
|
-$706,000.00
|
-$671,000.00
|
| Operating Expenses |
$208.59 M
|
$209.78 M
|
$214.56 M
|
$201.16 M
|
$175.33 M
|
$167.01 M
|
$188.48 M
|
$174.66 M
|
$139.06 M
|
$101.93 M
|
| Cost And Expenses |
$272.03 M
|
$270.91 M
|
$263.32 M
|
$248.84 M
|
$214.81 M
|
$206.45 M
|
$223.90 M
|
$214.18 M
|
$170.10 M
|
$126.32 M
|
| Interest Income |
$817,000.00
|
$499,000.00
|
$1.74 M
|
$2.44 M
|
$1.33 M
|
$383,000.00
|
$0.00
|
$0.00
|
$0.00
|
-$1.62 M
|
| Interest Expense |
$1.63 M
|
$1.74 M
|
$1.97 M
|
$1.68 M
|
$1.72 M
|
$500,000.00
|
$0.00
|
$23,000.00
|
$1.03 M
|
$1.35 M
|
| Depreciation & Amortization |
$1.34 M
|
$1.22 M
|
$1.23 M
|
$3.45 M
|
$3.93 M
|
$4.14 M
|
$3.92 M
|
$2.32 M
|
$1.37 M
|
$973,000.00
|
| EBITDA |
-$34.46 M |
-$10.72 M |
-$25.54 M |
-$825,000.00 |
$2.23 M |
-$1.54 M |
-$35.35 M |
-$32.64 M |
-$33.49 M |
-$22.42 M |
| EBITDA Ratio |
-0.15
|
-0.04
|
-0.11
|
-0
|
0.01
|
-0.01
|
-0.2
|
-0.18
|
-0.25
|
-0.22
|
| Operating Income Ratio |
-0.15
|
-0.05
|
-0.11
|
-0
|
-0.01
|
-0.01
|
-0.31
|
-0.18
|
-0.25
|
-0.22
|
| Total Other Income/Expenses Net |
-$817,000.00
|
-$1.24 M
|
-$233,000.00
|
$760,000.00
|
$3.54 M
|
-$164,000.00
|
$53,000.00
|
-$185,000.00
|
-$1.80 M
|
-$1.62 M
|
| Income Before Tax |
-$36.62 M
|
-$13.17 M
|
-$27.01 M
|
-$65,000.00
|
$1.84 M
|
-$1.71 M
|
-$56.02 M
|
-$32.82 M
|
-$35.29 M
|
-$24.04 M
|
| Income Before Tax Ratio |
-0.16
|
-0.05
|
-0.11
|
-0
|
0.01
|
-0.01
|
-0.31
|
-0.18
|
-0.26
|
-0.23
|
| Income Tax Expense |
$310,000.00
|
$252,000.00
|
$231,000.00
|
$190,000.00
|
$132,000.00
|
$86,000.00
|
$6.39 M
|
-$2.30 M
|
-$333,000.00
|
$344,000.00
|
| Net Income |
-$36.93 M
|
-$13.42 M
|
-$27.24 M
|
-$255,000.00
|
$1.71 M
|
-$1.79 M
|
-$56.02 M
|
-$32.82 M
|
-$35.29 M
|
-$24.04 M
|
| Net Income Ratio |
-0.16
|
-0.05
|
-0.12
|
-0
|
0.01
|
-0.01
|
-0.31
|
-0.18
|
-0.26
|
-0.23
|
| EPS |
-0.94 |
-0.35 |
-0.79 |
-0.0076 |
0.0509 |
-0.0554 |
-1.72 |
-1.04 |
-1.25 |
-1.11 |
| EPS Diluted |
-0.94 |
-0.35 |
-0.79 |
-0.0076 |
0.0509 |
-0.0554 |
-1.72 |
-1.04 |
-1.25 |
-1.11 |
| Weighted Average Shares Out |
$39.23 M
|
$38.83 M
|
$34.28 M
|
$33.54 M
|
$33.15 M
|
$32.37 M
|
$32.54 M
|
$31.55 M
|
$28.30 M
|
$21.69 M
|
| Weighted Average Shares Out Diluted |
$39.23 M
|
$38.83 M
|
$34.28 M
|
$33.54 M
|
$33.61 M
|
$32.37 M
|
$32.54 M
|
$31.55 M
|
$28.30 M
|
$21.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
